BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8808273)

  • 21. Evidence that fragile X mental retardation protein is a negative regulator of translation.
    Laggerbauer B; Ostareck D; Keidel EM; Ostareck-Lederer A; Fischer U
    Hum Mol Genet; 2001 Feb; 10(4):329-38. PubMed ID: 11157796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fragile X syndrome.
    de Vries BB; Halley DJ; Oostra BA; Niermeijer MF
    J Med Genet; 1998 Jul; 35(7):579-89. PubMed ID: 9678703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.
    Athar YM; Joseph S
    J Mol Biol; 2020 Jun; 432(13):3851-3868. PubMed ID: 32343993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular pathogenesis of fragile X syndrome].
    Sielska D; Milewski M; Bal J
    Med Wieku Rozwoj; 2002; 6(4):295-308. PubMed ID: 12810982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes.
    Darnell JC; Fraser CE; Mostovetsky O; Stefani G; Jones TA; Eddy SR; Darnell RB
    Genes Dev; 2005 Apr; 19(8):903-18. PubMed ID: 15805463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal model for fragile X syndrome.
    Oostra BA; Hoogeveen AT
    Ann Med; 1997 Dec; 29(6):563-7. PubMed ID: 9562525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid analysis of CGG repeat length in the FMR1 gene.
    Poon PM; Zhao Z; Wu XQ; Ni YX; Pang CP
    Clin Chem Lab Med; 2000 Sep; 38(9):935-8. PubMed ID: 11097353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures.
    Weisman-Shomer P; Cohen E; Fry M
    Nucleic Acids Res; 2000 Apr; 28(7):1535-41. PubMed ID: 10710419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
    Siomi H; Siomi MC; Nussbaum RL; Dreyfuss G
    Cell; 1993 Jul; 74(2):291-8. PubMed ID: 7688265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.
    Lugenbeel KA; Peier AM; Carson NL; Chudley AE; Nelson DL
    Nat Genet; 1995 Aug; 10(4):483-5. PubMed ID: 7670500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the molecular basis of fragile X syndrome.
    Jin P; Warren ST
    Hum Mol Genet; 2000 Apr; 9(6):901-8. PubMed ID: 10767313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of the G quartet forming semaphorin 3F RNA with the RGG box domain of the fragile X protein family.
    Menon L; Mihailescu MR
    Nucleic Acids Res; 2007; 35(16):5379-92. PubMed ID: 17693432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.
    Colak D; Zaninovic N; Cohen MS; Rosenwaks Z; Yang WY; Gerhardt J; Disney MD; Jaffrey SR
    Science; 2014 Feb; 343(6174):1002-5. PubMed ID: 24578575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fragile gene.
    Oostra BA; Willems PJ
    Bioessays; 1995 Nov; 17(11):941-7. PubMed ID: 8526888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.
    Menon RP; Gibson TJ; Pastore A
    J Mol Biol; 2004 Oct; 343(1):43-53. PubMed ID: 15381419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of FMRP with ribosomal precursor particles in the nucleolus.
    Willemsen R; Bontekoe C; Tamanini F; Galjaard H; Hoogeveen A; Oostra B
    Biochem Biophys Res Commun; 1996 Aug; 225(1):27-33. PubMed ID: 8769090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.